A detailed history of Cetera Investment Advisers transactions in Liquidia Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 29,966 shares of LQDA stock, worth $304,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,966
Previous 29,692 0.92%
Holding current value
$304,154
Previous $356,000 16.01%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.9 - $14.11 $2,438 - $3,866
274 Added 0.92%
29,966 $299,000
Q1 2024

May 24, 2024

BUY
$11.35 - $16.73 $337,004 - $496,747
29,692 New
29,692 $437,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $653M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.